Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 0.9787
- -0.0212-2.12%
Close Apr 28 16:00 ET
- 0.9787
- 0.00000.00%
Post 20:01 ET
23.48MMarket Cap-1.81P/E (TTM)
1.0200High0.9700Low119.84KVolume0.9761Open0.9999Pre Close118.73KTurnover1.01%Turnover RatioLossP/E (Static)23.99MShares1.500052wk High9.06P/B11.67MFloat Cap0.512052wk Low--Dividend TTM11.93MShs Float8.1800Historical High--Div YieldTTM5.00%Amplitude0.4000Historical Low0.9900Avg Price1Lot Size
About NeuroSense Therapeutics Company
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Company Profile
SymbolNRSN
Company NameNeuroSense Therapeutics
Listing DateDec 9, 2021
Issue Price5.99
Founded2017
CEOMr. Alon Ben-Noon
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address11 HaMenofim Street,Building B
CityHerzliya
ProvinceTel Aviv
CountryIsrael
Zip Code46725
Phone972-9-799-6183
Websitehttp://www.neurosense-tx.com
Company Executives
- Name
- Position
- Salary
- Alon Ben-Noon
- Chief Executive Officer and Director
- 388.00K
- Hagit Binder
- Chief Operating Officer
- 226.00K
- Or Eisenberg
- Chief Financial Officer
- 301.00K
- Dr. Niva Russek-Blum, B.Med.Sc.,M.Sc.,PhD
- Chief Technology Officer
- 217.00K
- Dr. Ferenc Tracik
- Chief Medical Officer
- 432.00K
- Mark W. Leuchtenberger
- Chairman of the Board
- --
- Dr. Revital Mandil-Levin, M.B.A.,PhD
- Director
- --
- Christine A. Pellizzari
- Independent Director
- --
- Roy Golan
- Independent Director
- --
- Cary J Claiborne
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts?
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
